BIBLIO is the largest independent book marketplace in the world, with over 100 million books.

Skip to content

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive
Stock photo: cover may vary

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline Hardback - 2017 - 1st Edition

by Bredesen, Dale

Add to wish list
  • Used
  • very good
  • Hardback
Used - Very good

Description

Avery Publishing Group, 2017. Hardcover. Very Good. Former library book; Missing dust jacket; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.Dust jacket quality is not guaranteed.
Ask the seller a question Add to wish list
A$9.31
Free Delivery within USA
Standard delivery: 4 to 8 days
More delivery options
Ships from ThriftBooks (Washington, United States)

Details

  • Title The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline
  • Author Bredesen, Dale
  • Binding Hardback
  • Edition number 1st
  • Edition 1
  • Condition Used - Very good
  • Pages 320
  • Volumes 1
  • Language ENG
  • Publisher Avery Publishing Group
  • Publication date 2017
  • Illustrated Yes
  • Features Bibliography, Illustrated, Index
  • Bookseller's Inventory # G0735216207I4N11
  • ISBN 9780735216204 / 0735216207
  • Weight 1.05 lbs (0.48 kg)
  • Dimensions 9.1 x 6.2 x 1.3 in (23.11 x 15.75 x 3.30 cm)
  • Themes
    • Topical: Health & Fitness
  • Category Consumer Health
  • Library of Congress subjects Alzheimer's disease - Prevention, Alzheimer's disease - Treatment
  • Library of Congress Catalogue Number 2017029515
  • Dewey Decimal Code 616.831
  • Quantity available 1

About ThriftBooks Washington, United States

Biblio member since 2018

From the largest selection of used titles, we put quality, affordable books into the hands of readers

Terms of Sale: 30 day return guarantee, with full refund including original shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

Browse books from ThriftBooks

Reader reviews for The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline

From the publisher

The instant New York Times and Wall Street Journal bestseller

A groundbreaking plan to prevent and reverse Alzheimer's Disease that fundamentally changes how we understand cognitive decline.

Everyone knows someone who has survived cancer, but until now no one knows anyone who has survived Alzheimer's Disease.

In this paradigm shifting book, Dale Bredesen, MD, offers real hope to anyone looking to prevent and even reverse Alzheimer's Disease and cognitive decline. Revealing that AD is not one condition, as it is currently treated, but three, The End of Alzheimer's outlines 36 metabolic factors (micronutrients, hormone levels, sleep) that can trigger "downsizing" in the brain. The protocol shows us how to rebalance these factors using lifestyle modifications like taking B12, eliminating gluten, or improving oral hygiene.

The results are impressive. Of the first ten patients on the protocol, nine displayed significant improvement with 3-6 months; since then the protocol has yielded similar results with hundreds more. Now, The End of Alzheimer's brings new hope to a broad audience of patients, caregivers, physicians, and treatment centers with a fascinating look inside the science and a complete step-by-step plan that fundamentally changes how we treat and even think about AD.

About the author

Dale Bredesen, M.D., is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his M.D. from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.
tracking-